{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:24:21Z","timestamp":1791919461089,"version":"4.3.4"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","award":["NT14054"],"award-info":[{"award-number":["NT14054"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.breast.2016.05.006","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T12:38:41Z","timestamp":1466080721000},"page":"136-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"special_numbering":"C","title":["Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management"],"prefix":"10.1016","volume":"28","author":[{"given":"Zdenek","family":"Kleibl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vessela N.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.breast.2016.05.006_bib1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa1400382","article-title":"Breast-cancer risk in families with mutations in PALB2","volume":"371","author":"Antoniou","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.breast.2016.05.006_bib2","article-title":"Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European Cancer Observatory","author":"Arnold","year":"2013","journal-title":"Eur J Cancer"},{"issue":"56","key":"10.1016\/j.breast.2016.05.006_bib4","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.1038\/sj.onc.1210881","article-title":"DNA damage signalling guards against activated oncogenes and tumour progression","volume":"26","author":"Bartek","year":"2007","journal-title":"Oncogene"},{"issue":"5449","key":"10.1016\/j.breast.2016.05.006_bib5","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1126\/science.286.5449.2528","article-title":"Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome","volume":"286","author":"Bell","year":"1999","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.breast.2016.05.006_bib6","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/ejhg.2014.16","article-title":"Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes","volume":"22","author":"Cast\u00e9ra","year":"2014","journal-title":"Eur J Hum Genet"},{"issue":"9291","key":"10.1016\/j.breast.2016.05.006_bib7","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(01)06524-2","article-title":"Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease","volume":"358","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"2001","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.breast.2016.05.006_bib8","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/aje\/152.10.950","article-title":"Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study","volume":"152","author":"Colditz","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"6178","key":"10.1016\/j.breast.2016.05.006_bib9","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1126\/science.1251827","article-title":"Two decades after BRCA: setting paradigms in personalized cancer care and prevention","volume":"343","author":"Couch","year":"2014","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.breast.2016.05.006_bib10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","article-title":"Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer","volume":"33","author":"Couch","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"7403","key":"10.1016\/j.breast.2016.05.006_bib11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.breast.2016.05.006_bib12","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1086\/426403","article-title":"CHEK2 is a multiorgan cancer susceptibility gene","volume":"75","author":"Cybulski","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.breast.2016.05.006_bib13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/ng.3284","article-title":"Germline RECQL mutations are associated with breast cancer susceptibility","volume":"47","author":"Cybulski","year":"2015","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.breast.2016.05.006_bib14","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1186\/bcr3669","article-title":"Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study","volume":"16","author":"Damiola","year":"2014","journal-title":"Breast Cancer Res"},{"issue":"5","key":"10.1016\/j.breast.2016.05.006_bib15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/emboj.2013.19","article-title":"A\u00a0new genome-driven integrated classification of breast cancer and its implications","volume":"32","author":"Dawson","year":"2013","journal-title":"EMBO J"},{"issue":"9","key":"10.1016\/j.breast.2016.05.006_bib16","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.breast.2016.05.006_bib17","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-panel sequencing and the prediction of breast-cancer risk","volume":"372","author":"Easton","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.breast.2016.05.006_bib18","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"issue":"15","key":"10.1016\/j.breast.2016.05.006_bib19","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.breast.2016.05.006_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju091","article-title":"Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis","volume":"106","author":"Friebel","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.breast.2016.05.006_bib21","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1186\/bcr2919","article-title":"Rare variants in the ATM gene and risk of breast cancer","volume":"13","author":"Goldgar","year":"2011","journal-title":"Breast Cancer Res"},{"issue":"8","key":"10.1016\/j.breast.2016.05.006_bib22","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1200\/JCO.2008.16.6959","article-title":"Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations","volume":"27","author":"Gonzalez","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.breast.2016.05.006_bib24","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1158\/1078-0432.CCR-06-0083","article-title":"Frequency and spectrum of cancers in the Peutz-Jeghers syndrome","volume":"12","author":"Hearle","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"14","key":"10.1016\/j.breast.2016.05.006_bib26","doi-asserted-by":"crossref","first-page":"7952","DOI":"10.1073\/pnas.151241198","article-title":"Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival","volume":"98","author":"Jain","year":"2001","journal-title":"Proc Natl Acad Sci U. S. A"},{"issue":"12","key":"10.1016\/j.breast.2016.05.006_bib27","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1158\/1055-9965.EPI-13-0745-T","article-title":"The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer","volume":"22","author":"Janatova","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"24","key":"10.1016\/j.breast.2016.05.006_bib28","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1001\/jama.298.24.2869","article-title":"Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial\/ethnic groups","volume":"298","author":"John","year":"2007","journal-title":"JAMA"},{"issue":"928562","key":"10.1016\/j.breast.2016.05.006_bib29","article-title":"A\u00a0comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer","volume":"2013","author":"Karami","year":"2013","journal-title":"Biomed Res Int"},{"issue":"21","key":"10.1016\/j.breast.2016.05.006_bib30","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1001\/jama.297.21.2360","article-title":"Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer","volume":"297","author":"Kaurah","year":"2007","journal-title":"JAMA"},{"issue":"6178","key":"10.1016\/j.breast.2016.05.006_bib31","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.343.6178.1457","article-title":"Breast cancer. The \u2018other\u2019 breast cancer genes","volume":"343","author":"Kean","year":"2014","journal-title":"Science"},{"issue":"42","key":"10.1016\/j.breast.2016.05.006_bib32","doi-asserted-by":"crossref","first-page":"15172","DOI":"10.1073\/pnas.1407909111","article-title":"Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer","volume":"111","author":"Kiiski","year":"2014","journal-title":"Proc Natl Acad Sci U. S. A"},{"issue":"2","key":"10.1016\/j.breast.2016.05.006_bib33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10549-004-4023-8","article-title":"The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic","volume":"90","author":"Kleibl","year":"2005","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.breast.2016.05.006_bib34","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/bjc.2014.306","article-title":"Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy","volume":"111","author":"Kriege","year":"2014","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.breast.2016.05.006_bib35","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1073\/pnas.1108781108","article-title":"Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling","volume":"109","author":"Kristensen","year":"2012","journal-title":"Proc Natl Acad Sci U. S. A"},{"issue":"10","key":"10.1016\/j.breast.2016.05.006_bib38","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.tibs.2012.06.007","article-title":"Links between genome integrity and BRCA1 tumor suppression","volume":"37","author":"Li","year":"2012","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"10.1016\/j.breast.2016.05.006_bib39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","article-title":"Environmental and heritable factors in the causation of cancer\u2013analyses of\u00a0cohorts of twins from Sweden, Denmark, and Finland","volume":"343","author":"Lichtenstein","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.breast.2016.05.006_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.molonc.2012.08.002","article-title":"Polymorphic variations in the FANCA gene in high-risk non-BRCA1\/2 breast cancer individuals from the French Canadian population","volume":"7","author":"Litim","year":"2013","journal-title":"Mol Oncol"},{"issue":"5","key":"10.1016\/j.breast.2016.05.006_bib41","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.7314\/APJCP.2012.13.5.2051","article-title":"The CHEK2 I157T variant and colorectal cancer susceptibility: a systematic review and meta-analysis","volume":"13","author":"Liu","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"10.1016\/j.breast.2016.05.006_bib42","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.7314\/APJCP.2012.13.4.1355","article-title":"The CHEK2 I157T variant and breast cancer susceptibility: a systematic review and meta-analysis","volume":"13","author":"Liu","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"10.1016\/j.breast.2016.05.006_bib43","first-page":"347","article-title":"Opportunities and strategies for breast cancer prevention through risk reduction","volume":"58","author":"Mahoney","year":"2008","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.breast.2016.05.006_bib44","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s10549-012-1993-9","article-title":"Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort","volume":"133","author":"Masciari","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.breast.2016.05.006_bib45","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/1055-9965.EPI-11-0775","article-title":"Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1\/2 (CIMBA)","volume":"21","author":"Mavaddat","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"10.1016\/j.breast.2016.05.006_bib46","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/gim.2014.176","article-title":"Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1\/2-negative patients with early-onset breast cancer","volume":"17","author":"Maxwell","year":"2015","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.breast.2016.05.006_bib47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng879","article-title":"Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations","volume":"31","author":"Meijers-Heijboer","year":"2002","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.breast.2016.05.006_bib48","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ng.2563","article-title":"Large-scale genotyping identifies 41 new loci associated with breast cancer risk","volume":"45","author":"Michailidou","year":"2013","journal-title":"Nat Genet"},{"issue":"5182","key":"10.1016\/j.breast.2016.05.006_bib49","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A\u00a0strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.breast.2016.05.006_bib50","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10549-011-1588-x","article-title":"Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes","volume":"132","author":"Nagel","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.breast.2016.05.006_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2010.01402.x","article-title":"Testing for CHEK2 in the cancer genetics clinic: ready for prime time?","volume":"78","author":"Narod","year":"2010","journal-title":"Clin Genet"},{"key":"10.1016\/j.breast.2016.05.006_bib52","first-page":"29","article-title":"Tamoxifen for women at high risk of breast cancer","volume":"6","author":"Nazarali","year":"2014","journal-title":"Breast Cancer (Dove Med Press)"},{"issue":"1","key":"10.1016\/j.breast.2016.05.006_bib53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10689-013-9674-3","article-title":"Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome","volume":"13","author":"Nieuwenhuis","year":"2014","journal-title":"Fam Cancer"},{"issue":"23","key":"10.1016\/j.breast.2016.05.006_bib54","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/jnci\/djj500","article-title":"BRCA mutation frequency and penetrance: new data, old debate","volume":"98","author":"Offit","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"21","key":"10.1016\/j.breast.2016.05.006_bib56","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/jnci\/djt277","article-title":"Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria","volume":"105","author":"Pilarski","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.breast.2016.05.006_bib57","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.0.CO;2-B","article-title":"Family history and the risk of breast cancer: a systematic review and meta-analysis","volume":"71","author":"Pharoah","year":"1997","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.breast.2016.05.006_bib58","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1172\/JCI33295","article-title":"Breast cancer: origins and evolution","volume":"117","author":"Polyak","year":"2007","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"10.1016\/j.breast.2016.05.006_bib59","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10549-006-9406-6","article-title":"The role of ATM in breast cancer development","volume":"104","author":"Prokopcova","year":"2007","journal-title":"Breast Cancer Res Treat"},{"issue":"7483","key":"10.1016\/j.breast.2016.05.006_bib60","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature12981","article-title":"Realizing the promise of cancer predisposition genes","volume":"505","author":"Rahman","year":"2014","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.breast.2016.05.006_bib61","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ng1837","article-title":"ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles","volume":"38","author":"Renwick","year":"2006","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.breast.2016.05.006_bib62","doi-asserted-by":"crossref","first-page":"R156","DOI":"10.1186\/bcr3369","article-title":"The risk of contralateral breast cancer in patients from BRCA1\/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study","volume":"14","author":"Rhiem","year":"2012","journal-title":"Breast Cancer Res"},{"issue":"3","key":"10.1016\/j.breast.2016.05.006_bib63","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10549-014-3097-1","article-title":"MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis","volume":"147","author":"Santoro","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.breast.2016.05.006_bib64","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/jmg.2010.079814","article-title":"Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers","volume":"48","author":"Schrader","year":"2011","journal-title":"J\u00a0Med Genet"},{"issue":"11","key":"10.1016\/j.breast.2016.05.006_bib65","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/ng1902","article-title":"Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles","volume":"38","author":"Seal","year":"2012","journal-title":"Nat Genet"},{"issue":"7403","key":"10.1016\/j.breast.2016.05.006_bib66","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature10933","article-title":"The clonal and mutational evolution spectrum of primary triple-negative breast cancers","volume":"486","author":"Shah","year":"2012","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.breast.2016.05.006_bib67","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/cge.12497","article-title":"BRCA1 and BRCA2 mutations and the risk for colorectal cancer","volume":"87","author":"Sopik","year":"2015","journal-title":"Clin Genet"},{"issue":"18","key":"10.1016\/j.breast.2016.05.006_bib68","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/j.ejca.2004.08.021","article-title":"Molecular portraits of breast cancer: tumour subtypes as distinct disease entities","volume":"40","author":"S\u00f8rlie","year":"2004","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.breast.2016.05.006_bib69","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/jmedgenet-2012-101037","article-title":"BRCA1 R1699Q variant displaying ambiguous functional abrogation confers\u00a0intermediate breast and ovarian cancer risk","volume":"49","author":"Spurdle","year":"2012","journal-title":"J\u00a0Med Genet"},{"issue":"7403","key":"10.1016\/j.breast.2016.05.006_bib70","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature11017","article-title":"The landscape of cancer genes and mutational processes in breast cancer","volume":"486","author":"Stephens","year":"2012","journal-title":"Nature"},{"issue":"7239","key":"10.1016\/j.breast.2016.05.006_bib71","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nature07943","article-title":"The cancer genome","volume":"458","author":"Stratton","year":"2009","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.breast.2016.05.006_bib72","doi-asserted-by":"crossref","first-page":"e1002894","DOI":"10.1371\/journal.pgen.1002894","article-title":"Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles","volume":"8","author":"Thompson","year":"2012","journal-title":"PLoS Genet"},{"issue":"4","key":"10.1016\/j.breast.2016.05.006_bib73","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.290.4.465","article-title":"Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease","volume":"290","author":"Travis","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.breast.2016.05.006_bib74","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.29010","article-title":"Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel","volume":"121","author":"Tung","year":"2015","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.breast.2016.05.006_bib77","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.295.12.1379","article-title":"Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast\u00a0cancer","volume":"295","author":"Walsh","year":"2006","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.breast.2016.05.006_bib78","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jnci\/91.14.1241","article-title":"Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer","volume":"91","author":"Warner","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.breast.2016.05.006_bib79","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1200\/JCO.2007.12.5922","article-title":"CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls","volume":"26","author":"Weischer","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"35","key":"10.1016\/j.breast.2016.05.006_bib80","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1200\/JCO.2012.42.7336","article-title":"CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer","volume":"30","author":"Weischer","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"6559","key":"10.1016\/j.breast.2016.05.006_bib81","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.breast.2016.05.006_bib82","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10654-014-9916-1","article-title":"Association between physical activity and mortality in breast cancer: a meta-analysis of cohort studies","volume":"29","author":"Zhong","year":"2014","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"10.1016\/j.breast.2016.05.006_bib83","doi-asserted-by":"crossref","first-page":"R26","DOI":"10.1186\/bcr1668","article-title":"Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study","volume":"9","author":"Broeks","year":"2007","journal-title":"Breast Cancer Res"},{"issue":"Pt 5","key":"10.1016\/j.breast.2016.05.006_bib84","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1042\/BST0340633","article-title":"Cellular functions of the BRCA tumour-suppressor proteins","volume":"34","author":"Boulton","year":"2006","journal-title":"Biochem Soc Trans"},{"issue":"11","key":"10.1016\/j.breast.2016.05.006_bib85","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1007\/s00330-010-1839-y","article-title":"Exposure to low-dose radiation and the risk of breast cancer among women with a familial or genetic predisposition: a meta-analysis","volume":"20","author":"Jansen-van der Weide","year":"2010","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.breast.2016.05.006_bib86","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/09553000110097974","article-title":"BRCA1 and BRCA2 heterozygosity and repair of X-ray-induced DNA damage","volume":"78","author":"Nieuwenhuis","year":"2002","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.breast.2016.05.006_bib87","doi-asserted-by":"crossref","first-page":"e5660","DOI":"10.1136\/bmj.e5660","article-title":"Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1\/2 mutations: retrospective cohort study (GENE-RAD-RISK)","volume":"345","author":"Pijpe","year":"2012","journal-title":"BMJ"},{"issue":"37","key":"10.1016\/j.breast.2016.05.006_bib88","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1038\/sj.onc.1206678","article-title":"Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation","volume":"22","author":"Powell","year":"2003","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.breast.2016.05.006_bib89","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(02)00615-3","article-title":"Cancer susceptibility and the functions of BRCA1 and BRCA2","volume":"108","author":"Venkitaraman","year":"2002","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.breast.2016.05.006_bib90","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1349-7006.2004.tb02195.x","article-title":"Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage","volume":"95","author":"Yoshida","year":"2004","journal-title":"Cancer Sci"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977616300650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977616300650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:37:03Z","timestamp":1760776623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977616300650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":82,"alternative-id":["S0960977616300650"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2016.05.006","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2016.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}